Yvonne Bombard/LinkedIn
May 15, 2025, 08:15
Yvonne Bombard: Proud to represent the amazing Genetics Adviser team at 2025 MaRS Discovery District
Yvonne Bombard, Canada Research Chair at Unity Health Toronto and a Professor at the University of Toronto, shared a post by Genetics Adviser on LinkedIn, adding:
“Proud to represent the amazing team at Genetics Adviser – a passionate group committed to making precision medicine more accessible, patient-centred, and equitable on a global scale.
We’re driven by a shared belief: that everyone deserves access to the power of personalized healthcare.
A heartfelt thank you to our growing network of supporters and partners who are helping us accelerate this mission:
Together, we’re not just advancing innovation – we’re building a future where precision medicine is the standard, not the exception.”
Quoting Genetics Advisor‘s post:
“We loved being part of Impact Health at MaRS last week – what an incredible gathering of people reimagining the future of healthcare.
Huge shoutout to our founder Dr. Yvonne Bombard for presenting on behalf of Genetics Adviser, sharing how we’re using tech to make precision medicine more accessible, personal, and scalable.
Big thanks to the team at MaRS Discovery District for bringing everyone together – it’s always inspiring to connect with others who are just as passionate about transforming care.”
More posts featuring Yvonne Bombard on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 16, 2025, 00:23
May 15, 2025, 18:17
May 15, 2025, 17:41
May 15, 2025, 17:00
May 15, 2025, 16:42